Cantor Fitzgerald analyst Olivia Brayer initiated coverage with a Hold rating on Alnylam Pharma (ALNY – Research Report) yesterday and set a ...
Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on MannKind (MNKD – Research Report) yesterday and set a price target of $9.00.
Tuesday, Cantor Fitzgerald reaffirmed its Overweight ... The firm's analyst, Olivia Brayer, provided insights into the pharmaceutical company's prospects, particularly focusing on the potential ...